The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) progresses to nonalcoholic steatohepatitis (NASH) in response to elevated endoplasmic reticulum (ER) stress. Whereas the onset of simple steatosis requires elevated de novo lipogenesis, progression to NASH is triggered by accumulation of hepatocyte-free cholesterol. We now show that caspase-2, whose expression is ER-stress inducible and elevated in human and mouse NASH, controls the buildup of hepatic-free cholesterol and triglycerides by activating sterol regulatory element-binding proteins (SREBP) in a manner refractory to feedback inhibition. Caspase-2 colocalizes with site 1 protease (S1P) and cleaves it to generate a soluble active fragment that initiates SCAP-independent SREBP1/2 activation in the ER. Caspase-2 ablation or pharmacological inhibition prevents diet-induced steatosis and NASH progression in ER-stress-prone mice. Caspase-2 inhibition offers a specific and effective strategy for preventing or treating stress-driven fatty liver diseases, whereas caspase-2-generated S1P proteolytic fragments, which enter the secretory pathway, are potential NASH biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A study showed that ER-stress-mediated SREBP1/2 activation, TG and cholesterol accumulation, as well as MASH progression, all depend on Casp2 [91].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [91]
In the citing paper
“Thus, ER stress might contribute to the development of increased hepatic DNL in hepatic IR, at least in the advanced stages of MASLD/MASH [91].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Self-citationBrown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Feldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Self-citationLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“One metabolic process thought to initiate NAFLD is de novo lipogenesis (DNL), whose rate is up to 3-fold higher in NAFLD patients (Lambert et al., 2014).”
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 1,000
Cited by
Sorted by citations
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Self-citationMechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 548
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. A. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 539
Insulin signaling in health and disease
Saltiel, A. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142241 · Cited by 446
Self-citationRole of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Endoplasmic reticulum stress in liver diseases
Ajoolabady, A., Kaplowitz, N., Lebeaupin, C., Kroemer, G., Kaufman, R. J., Malhi, H., & Ren, J. T. (2022) · Hepatology · doi:10.1002/hep.32562 · Cited by 428
Self-citationA new perspective on NAFLD: Focusing on lipid droplets
Scorletti, E., & Carr, R. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.009 · Cited by 394
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 352
Fructose stimulated de novo lipogenesis is promoted by inflammation
Todoric, J., Di Caro, G., Reibe, S., Henstridge, D. C., Green, C. R., Vrbanac, A., Ceteci, F., Conche, C., McNulty, R., Shalapour, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0261-2 · Cited by 328
Self-citationCholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Song, Y., Liu, J., Zhao, K. Z., Gao, L., & Zhao, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.001 · Cited by 339
An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Zhao, P., Sun, X., Chaggan, C., Liao, Z., Wong, K. I., He, F., Singh, S., Loomba, R. S., Karin, M., Witztum, J. L., et al. (2020) · Science · doi:10.1126/science.aay0542 · Cited by 312
Self-citationHigh fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
Lian, C.-Y., Zhai, Z., Li, Z., & Wang, L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109199 · Cited by 325
Molecular aspects of fructose metabolism and metabolic disease
Herman, M. A., & Birnbaum, M. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.010 · Cited by 315
Hou, J., Zhang, J., Cui, P., Zhou, Y., Liu, C., Wu, X., Ji, Y., Wang, S., Cheng, B., Ye, H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135197 · Cited by 239
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 239
Ma, H.-Y., Yamamoto, G., Xu, J., Liu, X., Karin, D., Kim, J. Y., Alexandrov, L. B., Koyama, Y., Nishio, T., Benner, C., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.016 · Cited by 216
Self-citationCholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204
A long way to go: caspase inhibitors in clinical use
Dhani, S., Zhao, Y., & Zhivotovsky, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04240-3 · Cited by 216
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Febbraio, M. A., & Karin, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.004 · Cited by 185
Self-citationSREBP-1c and lipogenesis in the liver: an update
Ferré, P., Phan, F., & Foufelle, F. (2021) · Biochemical Journal · doi:10.1042/bcj20210071 · Cited by 183
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Rives, C., Fougerat, A., Ellero‐Simatos, S., Loiseau, N., Guillou, H., Gamet‐Payrastre, L., & Wahli, W. (2020) · Biomolecules · doi:10.3390/biom10121702 · Cited by 167
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis
Huang, D., Xu, B., Liu, L., Wu, L., Zhu, Y., Ghanbarpour, A., Wang, Y., Chen, F., Lyu, J., Hu, Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.006 · Cited by 157
Fan, Y., & Simmen, T. (2019) · Cells · doi:10.3390/cells8091071 · Cited by 145
Yahoo, N., Dudek, M., Knolle, P. A., & Heikenwälder, M. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 147
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
Li, N., Li, X., Ding, Y., Liu, X., Diggle, K., Kisseleva, T., & Brenner, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123280 · Cited by 146
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
He, Y., Hwang, S., Ahmed, Y. A., Feng, D., Li, N., Ribeiro, M. D. C., Lafdil, F., Kisseleva, T., Szabó, G., & Gao, B. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00580-w · Cited by 140
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Wei, S., Qiu, T., Wang, N., Yao, X., Jiang, L., Jia, X., Tao, Y., Zhang, J., Zhu, Y., Yang, G., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109824 · Cited by 129
FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease
Liu, C., Zhou, B., Meng, M., Zhao, W., Wang, D., Yuan, Y., Zheng, Y. F., Qiu, J. F., Li, Y., Li, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.042 · Cited by 124
Kawamura, S., Matsushita, Y., Kurosaki, S., Tange, M., Fujiwara, N., Hayata, Y., Hayakawa, Y., Suzuki, N., Hata, M., Tsuboi, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151895 · Cited by 117
Podszun, M. C., Alawad, A. S., Lingala, S., Morris, N., Huang, W. A., Yang, S. B., Schoenfeld, M., Rolt, A., Ouwerkerk, R., Valdez, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101710 · Cited by 115
de la Rosa, L. C., García‐Ruiz, C., Vallejo, C., Baulies, A., Núñez, S., Monte, M. J., Marı́n, J. J. G., Baila-Rueda, L., Cenarro, A., Civeira, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.028 · Cited by 101
Self-citationKanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 97
Zhou, Y., Li, P., Wang, X., Wu, C., Fan, N., Liu, X., Wu, L., Zhang, W., Zhang, W., Liu, Z., et al. (2020) · Chemical Science · doi:10.1039/d0sc02922j · Cited by 88
The metabolic basis of nonalcoholic steatohepatitis
Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 93
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“A study showed that ER-stress-me-diated SREBP1/2 activation, TG and cholesterol accumulation, as well as MASH progression, all depend on Casp2 [91].”
Donné, R., Saroul-Aïnama, M., Cordier, P., Hammoutène, A., Kaboré, C., Stadler, M., Nemazanyy, I., Galy–Fauroux, I., Herrag, M., Riedl, T., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.06.003 · Cited by 85
P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
Zhu, Y., Gu, L., Lin, X., Zhou, X., Lu, B., Liu, C., Li, Y., Prochownik, E. V., Karin, M., Wang, X., et al. (2022) · Hepatology · doi:10.1002/hep.32518 · Cited by 82
Self-citationLi, S., Li, X., Chen, F., Liu, M., Ning, L., Yan, Y.-F., Zhang, S., Huang, S., & Tu, C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108888 · Cited by 73
Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma
Wei, J., & Fang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041799 · Cited by 68
Sladky, V. C., Knapp, K., Soratroi, C., Heppke, J., Eichin, F., Rocamora‐Reverte, L., Szabó, T. G., Bongiovanni, L., Westendorp, B., Moreno, E., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2019.12.016 · Cited by 69
The role of exosomal miRNA in nonalcoholic fatty liver disease
Mahmoudi, A., Butler, A., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30699 · Cited by 56
El-Derany, M. O., & AbdelHamid, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114624 · Cited by 64
Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction–Associated Steatohepatitis
Kisseleva, T., Ganguly, S., Murad, R., Wang, A., & Brenner, D. A. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.010 · Cited by 75
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Tak, J., Kim, Y. S., Kim, T. H., Park, G., Hwang, S., & Kim, S. G. (2022) · Theranostics · doi:10.7150/thno.67722 · Cited by 63
Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Hawiger, J., & Zienkiewicz, J. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12812 · Cited by 62
Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
Overi, D., Carpino, G., Franchitto, A., Onori, P., & Gaudio, E. (2020) · Cells · doi:10.3390/cells9030590 · Cited by 62
Caspase-2 Substrates: To Apoptosis, Cell Cycle Control, and Beyond
Brown-Suedel, A. N., & Bouchier‐Hayes, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.610022 · Cited by 62
Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus
Sule, G. J., Abuaita, B. H., Steffes, P. A., Fernandes, A. T., Estes, S. K., Dobry, C. J., Pandian, D., Gudjonsson, J. E., Kahlenberg, J. M., O’Riordan, M. X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137866 · Cited by 62
Interleukin-17 in Liver Disease Pathogenesis
Li, N., Yamamoto, G., Fuji, H., & Kisseleva, T. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1730926 · Cited by 64
Endoplasmic reticulum stress in diseases
Liu, Y., Xu, C., Gu, R., Han, R., Li, Z., & Xu, X. (2024) · MedComm · doi:10.1002/mco2.701 · Cited by 67
Jia, H., Liu, J., Fang, T., Zhou, Z. D., Li, R., Yin, W., Qian, Y., Wang, Q., Zhou, W., Liu, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq2937 · Cited by 58
Ali, E. S., Rychkov, G. Y., & Barritt, G. J. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.102057 · Cited by 58
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 59
Jiang, S., Yang, X., Yang, Z., Li, J., Xu, M., Qu, Y.-X., Tang, J., Li, Y., Wang, L., Shao, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32381 · Cited by 58
Treating inflammation to combat non-alcoholic fatty liver disease
Wiering, L., & Tacke, F. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 59
Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?
Ipsen, D. H., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa081 · Cited by 59
The p53-caspase-2 axis in the cell cycle and DNA damage response
Lim, Y. P., Dorstyn, L., & Kumar, S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00590-2 · Cited by 54
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Lin, H., Mak, B., Yeung, N. K., Huynh, K., Meikle, T. G., Mellett, N. A., Kwan, E. M., Fettke, H., Tran, B., Davis, I. D., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103625 · Cited by 57
Zhou, Y., Liu, Z., Qiao, G., Tang, B., & Li, P. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.04.035 · Cited by 55
p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
Tan, C. T., Soh, N. J. H., Chang, H., & Yu, V. C. K. (2021) · FEBS Journal · doi:10.1111/febs.16317 · Cited by 52
Fowler, J. W., Zhang, R., Tao, B., Boutagy, N. E., & Sessa, W. C. (2022) · eLife · doi:10.7554/elife.79529 · Cited by 51
Mollica, G., Senesi, P., Codella, R., Vacante, F., Montesano, A., Luzi, L., & Terruzzi, I. M. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.09.002 · Cited by 52
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Steensels, S., Qiao, J., & Ersoy, B. A. (2020) · Metabolites · doi:10.3390/metabo10070283 · Cited by 53
MITOCHONDRIAL CHOLESTEROL AND CANCER
García‐Ruiz, C., de la Rosa, L. C., Ribas, V., & Fernández-Checa, J. C. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.014 · Cited by 55
PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis
Sladky, V. C., Knapp, K., Szabó, T. G., Braun, V. Z., Bongiovanni, L., van den Bos, H., Spierings, D. C. J., Westendorp, B., Curinha, A., Stojaković, T., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050893 · Cited by 51
Li, C., Cai, C., Wang, C., Chen, X., Zhang, B., & Huang, Z. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0857 · Cited by 57
Morgan, P. K., Fang, L., Lancaster, G. I., & Murphy, A. J. (2019) · Journal of Lipid Research · doi:10.1194/jlr.tr119000267 · Cited by 51
Rao, S., Yang, X., Ohshiro, K., Zaidi, S., Wang, Z., Shetty, K., Xiang, X., Hassan, M. I., Mohammad, T., Latham, P. S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abk2267 · Cited by 47
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 55
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
Schwabe, R. F., Tacke, F., Sugimoto, A., & Friedman, S. L. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101421 · Cited by 52
Eilam, Y., Pintel, N., Khattib, H., Shagug, N., Taha, R., & Avni, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213667 · Cited by 50
Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation
Sladky, V. C., & Villunger, A. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0556-6 · Cited by 39
NIRANJAN, S., Phillips, B. E., & Giannoukakis, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193373 · Cited by 44
Phospholipid Membrane Transport and Associated Diseases
Ventura, R., Martínez-Ruíz, I., & Hernández‐Álvarez, M. I. (2022) · Biomedicines · doi:10.3390/biomedicines10051201 · Cited by 43
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., Dong, Y., Wang, M., Li, Y., Lu, S., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01381-6 · Cited by 44
Gu, L., Zhu, Y., Watari, K., Lee, M., Liu, J., Perez, S., Thai, M., Mayfield, J. E., Zhang, B., Rocha, K. C. E., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.021 · Cited by 43
Self-citationKuan, Y.-C., Takahashi, Y., Maruyama, T., Shimizu, M., Yamauchi, Y., & Sato, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011849 · Cited by 40
Endoplasmic Reticulum Stress in Biological Processing and Disease
Köksal, A. R., Verne, G. N., & Zhou, Q. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001570 · Cited by 41
Shin, S., You, I., Jeong, M., Bae, Y., Wang, X., Cawley, M. L., Han, A., & Lim, B. K. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01208-0 · Cited by 42
Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review
Shreya, S., Grosset, C. F., & Jain, B. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814066 · Cited by 42
Kisseleva, T., & Brenner, D. A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.010 · Cited by 39
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Karin, M., & Kim, J. Y. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13685 · Cited by 45
Self-citationBarbhuiya, P. A., Yoshitomi, R., & Pathak, M. P. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00626-y · Cited by 44
Deng, X., Ye, Z., Cao, H., Bai, Y., Che, Q., Guo, J., & Su, Z. (2020) · Food & Function · doi:10.1039/d0fo01107j · Cited by 39
Li, R., Li, Y., Yang, X., Yu, H., Yu, H., & Li, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03540-2 · Cited by 38
ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH
Liu, Y. J., Kimura, M., Li, X., Sulc, J., Wang, Q., Rodríguez-López, S., Scantlebery, A. M. L., Strotjohann, K., Gallart‐Ayala, H., Vijayakumar, A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.009 · Cited by 42
Angelini, G., Castagneto‐Gissey, L., Salinari, S., BERTUZZI, A., Anello, D., Pradhan, M., Zschätzsch, M., Ritter, P., le Roux, C. W., Rubino, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35310-5 · Cited by 39
Multi-walled carbon nanotubes promoted lipid accumulation in human aortic smooth muscle cells
Yang, H., Li, J., Yang, C., Liu, H., & Cao, Y. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.04.022 · Cited by 36
Kim, J. Y., Wang, L. Q., Sladky, V. C., Oh, T. G., Liu, J., Trinh, K., Eichin, F., Downes, M., Hosseini, M., Jacotot, E. D., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.005 · Cited by 37
Self-citationPark, S., Helsley, R. N., Fadhul, T., Willoughby, J. L. S., Noetzli, L. J., Tu, H.-C., Solheim, M. H., Fujisaka, S., Pan, H., Dreyfuss, J. M., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155591 · Cited by 37
Pan, Y., Wang, Y., Tang, W., Sun, W., Ma, Y., Lin, S., Jing, J., Jiang, L., Shi, H., Song, Z., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61473-6 · Cited by 35
Wang, Y.-L., Zhou, X., Li, D., & Ye, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00629-0 · Cited by 36
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice
Weber, A. A., Yang, X., Mennillo, E., Ding, J., Watrous, J. D., Jain, M., Chen, S., Karin, M., & Tukey, R. H. (2022) · Nature Communications · doi:10.1038/s41467-022-31947-4 · Cited by 30
Self-citation
Metadata
- Authors
- Kim, J. Y., Garcia-Carbonell, R., Yamachika, S., Zhao, P., Dhar, D., Loomba, R., Kaufman, R. J., Saltiel, A. R., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Karin, Michael
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 175
- Issue
- 1
- Pages
- 133-145.e15
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6159928
- OpenAlex
- W2890819762
- Cited by
- 333
- References
- 59
- Citations by year
- 2026: 16 · 2025: 45 · 2024: 48 · 2023: 49 · 2022: 49 · 2021: 49 · 2020: 49 · 2019: 24 · 2018: 4
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH
- NCI (R01CA211794, R01CA198103, R01CA155120)
- NIEHS (P42ES010337)
- NHMRC (APP112227)
- AACR-Bayer Hepatocellular Carcinoma Fellowship (16-40-44-KIMJ)
- Diabetes Research Center Pilot and Feasibility Grant (P30DK063491)
- Boehringer Ingelheim Fonds
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- endoplasmic reticulum stress, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, caspase-2, site-1 protease, de novo lipogenesis, hepatic steatosis, free cholesterol accumulation, triglyceride accumulation
- MeSH terms
- Animals, Cholesterol, Endoplasmic Reticulum, Fatty Liver, Humans, Liver, Mice, Inbred C57BL, Serine Endopeptidases, Triglycerides, Hepatocytes, Proprotein Convertases, Lipogenesis, Mice, Sterol Regulatory Element Binding Protein 1, Caspase 2, HEK293 Cells, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
